Impact News +++ Hive Digital expands BUZZ HPC with new cluster in Quebec, acquires Toronto facility to fuel growth (Proactive Investors) +++ HIVE DIGITAL Aktie -3,44%

GENENTA Aktie

>GENENTA Performance

1 Woche: 0%

1 Monat: -17,0%

3 Monate: -9,9%

6 Monate: -40,4%

1 Jahr: +6,6%

laufendes Jahr: -33,6%

>GENENTA Aktie

Name:

GENENTA SCIENCE(SP.ADR)/1

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US36870W1009 / A3C9EK

Symbol/ Ticker:

K5F (Frankfurt) / GNTA (NASDAQ)

Kürzel:

FRA:K5F, ETR:K5F, K5F:GR, NASDAQ:GNTA

Index:

Webseite:

https://www.genenta.com/

Marktkapitalisierung:

61.58 Mio. EUR

Umsatz:

EBITDA:

-8.44 Mio. EUR

Gewinn je Aktie:

-0.426 EUR

Schulden:

0.01 Mio. EUR

Liquide Mittel:

11 Mio. EUR

Umsatz-/ Gewinnwachstum:

- / -

KGV/ KGV lG:

- / -

KUV/ KBV/ PEG:

- / 4.42 / -

Gewinnm./ Eigenkapitalr.:

- / -54.13%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

GENENTA

Letzte Datenerhebung:

24.06.25

>GENENTA Eigentümer

Aktien: 18.29 Mio. St.

f.h. Aktien: 11.22 Mio. St.

Insider Eigner: 39.15%

Instit. Eigner: 9.82%

Leerverk. Aktien: 0.01%

>GENENTA Peer Group

ASPEN PHARMACARE ADR

CIDARA

CLENE

HEALTHCARE SERVICES GROUP

HOYA CORP ADR

KIORA PHARMACEUTICALS

LUNGLIFE AI

SOLVENTUM

STARPHARMA ADR

STRATA SKIN

>GENENTA Chart & Kurs - NASDAQ

>GENENTA News

08.05.25 - 13:06	D.Boral Capital: Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference (Newsfile)
	Milan, Italy and New York, New York--(Newsfile Corp. - May 8, 2025) - Genenta Science, SpA (NASDAQ: GNTA), today announced its participation in the D. Boral Capital Inaugural Global Conference, ta......

15.04.25 - 11:03	Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar (GlobeNewswire EN)
	CEO Genenta Science (Nasdaq: GNTA) will present at “Montalcini Global Biotech Tour Doha April 17, 2025...

19.03.25 - 14:30	Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates (GlobeNewswire EN)
	Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates...

09.01.25 - 12:18	Genenta strengthens agreement with AGC Biologics to boost cell therapy manufacturing (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.10.24 - 13:06	Genenta′s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” (GlobeNewswire EN)
	Genenta's CEO to present at the U.S. Senate, Washington D.C.at the meeting “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatl...

02.10.24 - 12:33	Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer (GlobeNewswire EN)
	Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram